首页 | 本学科首页   官方微博 | 高级检索  
     

熊去氧胆酸联合复方甘草酸苷治疗原发性胆汁性肝硬化临床疗效观察
引用本文:邹科文. 熊去氧胆酸联合复方甘草酸苷治疗原发性胆汁性肝硬化临床疗效观察[J]. 中国医药导报, 2011, 8(36): 82-83
作者姓名:邹科文
作者单位:广东省深圳市宝安区中医院,广东深圳,518133
摘    要:
目的:探讨熊去氧胆酸(UDCA)联合复方甘草酸苷治疗原发性胆汁性肝硬化(PBC)的临床疗效。方法:将42例PBC患者随机分为对照组和治疗组,各21例,对照组给予UDCA治疗,治疗组在对照组用药的基础上给予复方甘草酸苷静滴,4~6周后比较治疗前后及两组临床症状的改善情况及相关生化指标的变化。结果:两组患者治疗后临床症状及相关生化指标均明显改善,且治疗组改善优于对照组,差异有统计学意义(P〈0.05)。结论:熊去氧胆酸联合复方甘草酸苷治疗PBC,疗效显著,安全性好,值得在临床推广。

关 键 词:原发性胆汁性肝硬化  熊去氧胆酸  复方甘草酸苷

Observation of clinical effect on Ursodeoxycholic Acid combined with Compound Glycyrrhizin in the treatment of primary biliary cirrhosis
ZOU Kewen. Observation of clinical effect on Ursodeoxycholic Acid combined with Compound Glycyrrhizin in the treatment of primary biliary cirrhosis[J]. China Medical Herald, 2011, 8(36): 82-83
Authors:ZOU Kewen
Affiliation:ZOU Kewen Bao'an District Hospital of Traditional Chinese Medicine in Shenzhen City,Guangdong Province,Shenzhen 518133,China
Abstract:
Objective:To discuss the clinical effects of Ursodeoxycholic Acid(UDCA) combined with Compound Glycyrrhizin in the treatment of primary biliary cirrhosis(PBC).Methods:42 patients with PBC were randomly divided into control group and treatment group,with 21 cases in each group.Control group was conducted with UDCA treatment,and the treatment group was compounded Glycyrrhizin infusion based on the treatment of control group.The changes of clinical improved situations and relevant biochemical indicators were c...
Keywords:Primary biliary cirrhosis  Ursodeoxycholic Acid  Compound Glycyrrhizin  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号